Coherus BioSciences, Inc. earnings per share and revenue

CHRS earnings per share for the last quarter are -0.71 USD whereas the estimation was -0.21 USD which accounts for -243.15% surprise. Company revenue for the same period amounts to 91.52 M USD despite the estimated figure of 96.89 M USD. Estimated earnings per share for the next quarter are -0.25 USD, and revenue is expected to reach 81.70 M USD. Also watch annual changes over time to get a bigger picture of CHRS earnings per share and revenue dynamics.